Ibandronate Market, Global Outlook and Forecast 2022-2028

March 2022 | 63 pages | ID: IA97F57918C7EN
Market Monitor Global

Abstracts

Ibandronate is prescription medication used for treating osteoporosis in women after menopause.

This report contains market size and forecasts of Ibandronate in Global, including the following market information:

Global Ibandronate Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Ibandronate market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Ibandronate include Roche, Apotex, Mylan, Sun Pharmaceutical, Dr Reddy's Laboratories, Aurobindo Pharma and MACLEODS, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ibandronate companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Ibandronate Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Ibandronate Market Segment Percentages, by Type, 2021 (%)

• Oral
• Injection

Global Ibandronate Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Ibandronate Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Drug store

Global Ibandronate Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Ibandronate Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Ibandronate revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Ibandronate revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Roche
• Apotex
• Mylan
• Sun Pharmaceutical
• Dr Reddy's Laboratories
• Aurobindo Pharma
• MACLEODS

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Ibandronate Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Ibandronate Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL IBANDRONATE OVERALL MARKET SIZE

2.1 Global Ibandronate Market Size: 2021 VS 2028
2.2 Global Ibandronate Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Ibandronate Players in Global Market
3.2 Top Global Ibandronate Companies Ranked by Revenue
3.3 Global Ibandronate Revenue by Companies
3.4 Top 3 and Top 5 Ibandronate Companies in Global Market, by Revenue in 2021
3.5 Global Companies Ibandronate Product Type
3.6 Tier 1, Tier 2 and Tier 3 Ibandronate Players in Global Market
  3.6.1 List of Global Tier 1 Ibandronate Companies
  3.6.2 List of Global Tier 2 and Tier 3 Ibandronate Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Ibandronate Market Size Markets, 2021 & 2028
  4.1.2 Oral
  4.1.3 Injection
4.2 By Type - Global Ibandronate Revenue & Forecasts
  4.2.1 By Type - Global Ibandronate Revenue, 2017-2022
  4.2.2 By Type - Global Ibandronate Revenue, 2023-2028
  4.2.3 By Type - Global Ibandronate Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Ibandronate Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Drug store
5.2 By Application - Global Ibandronate Revenue & Forecasts
  5.2.1 By Application - Global Ibandronate Revenue, 2017-2022
  5.2.2 By Application - Global Ibandronate Revenue, 2023-2028
  5.2.3 By Application - Global Ibandronate Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Ibandronate Market Size, 2021 & 2028
6.2 By Region - Global Ibandronate Revenue & Forecasts
  6.2.1 By Region - Global Ibandronate Revenue, 2017-2022
  6.2.2 By Region - Global Ibandronate Revenue, 2023-2028
  6.2.3 By Region - Global Ibandronate Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Ibandronate Revenue, 2017-2028
  6.3.2 US Ibandronate Market Size, 2017-2028
  6.3.3 Canada Ibandronate Market Size, 2017-2028
  6.3.4 Mexico Ibandronate Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Ibandronate Revenue, 2017-2028
  6.4.2 Germany Ibandronate Market Size, 2017-2028
  6.4.3 France Ibandronate Market Size, 2017-2028
  6.4.4 U.K. Ibandronate Market Size, 2017-2028
  6.4.5 Italy Ibandronate Market Size, 2017-2028
  6.4.6 Russia Ibandronate Market Size, 2017-2028
  6.4.7 Nordic Countries Ibandronate Market Size, 2017-2028
  6.4.8 Benelux Ibandronate Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Ibandronate Revenue, 2017-2028
  6.5.2 China Ibandronate Market Size, 2017-2028
  6.5.3 Japan Ibandronate Market Size, 2017-2028
  6.5.4 South Korea Ibandronate Market Size, 2017-2028
  6.5.5 Southeast Asia Ibandronate Market Size, 2017-2028
  6.5.6 India Ibandronate Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Ibandronate Revenue, 2017-2028
  6.6.2 Brazil Ibandronate Market Size, 2017-2028
  6.6.3 Argentina Ibandronate Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Ibandronate Revenue, 2017-2028
  6.7.2 Turkey Ibandronate Market Size, 2017-2028
  6.7.3 Israel Ibandronate Market Size, 2017-2028
  6.7.4 Saudi Arabia Ibandronate Market Size, 2017-2028
  6.7.5 UAE Ibandronate Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Roche
  7.1.1 Roche Corporate Summary
  7.1.2 Roche Business Overview
  7.1.3 Roche Ibandronate Major Product Offerings
  7.1.4 Roche Ibandronate Revenue in Global Market (2017-2022)
  7.1.5 Roche Key News
7.2 Apotex
  7.2.1 Apotex Corporate Summary
  7.2.2 Apotex Business Overview
  7.2.3 Apotex Ibandronate Major Product Offerings
  7.2.4 Apotex Ibandronate Revenue in Global Market (2017-2022)
  7.2.5 Apotex Key News
7.3 Mylan
  7.3.1 Mylan Corporate Summary
  7.3.2 Mylan Business Overview
  7.3.3 Mylan Ibandronate Major Product Offerings
  7.3.4 Mylan Ibandronate Revenue in Global Market (2017-2022)
  7.3.5 Mylan Key News
7.4 Sun Pharmaceutical
  7.4.1 Sun Pharmaceutical Corporate Summary
  7.4.2 Sun Pharmaceutical Business Overview
  7.4.3 Sun Pharmaceutical Ibandronate Major Product Offerings
  7.4.4 Sun Pharmaceutical Ibandronate Revenue in Global Market (2017-2022)
  7.4.5 Sun Pharmaceutical Key News
7.5 Dr Reddy's Laboratories
  7.5.1 Dr Reddy's Laboratories Corporate Summary
  7.5.2 Dr Reddy's Laboratories Business Overview
  7.5.3 Dr Reddy's Laboratories Ibandronate Major Product Offerings
  7.5.4 Dr Reddy's Laboratories Ibandronate Revenue in Global Market (2017-2022)
  7.5.5 Dr Reddy's Laboratories Key News
7.6 Aurobindo Pharma
  7.6.1 Aurobindo Pharma Corporate Summary
  7.6.2 Aurobindo Pharma Business Overview
  7.6.3 Aurobindo Pharma Ibandronate Major Product Offerings
  7.6.4 Aurobindo Pharma Ibandronate Revenue in Global Market (2017-2022)
  7.6.5 Aurobindo Pharma Key News
7.7 MACLEODS
  7.7.1 MACLEODS Corporate Summary
  7.7.2 MACLEODS Business Overview
  7.7.3 MACLEODS Ibandronate Major Product Offerings
  7.7.4 MACLEODS Ibandronate Revenue in Global Market (2017-2022)
  7.7.5 MACLEODS Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Ibandronate Market Opportunities & Trends in Global Market
Table 2. Ibandronate Market Drivers in Global Market
Table 3. Ibandronate Market Restraints in Global Market
Table 4. Key Players of Ibandronate in Global Market
Table 5. Top Ibandronate Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Ibandronate Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Ibandronate Revenue Share by Companies, 2017-2022
Table 8. Global Companies Ibandronate Product Type
Table 9. List of Global Tier 1 Ibandronate Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ibandronate Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Ibandronate Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Ibandronate Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Ibandronate Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Ibandronate Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Ibandronate Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Ibandronate Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Ibandronate Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Ibandronate Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Ibandronate Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Ibandronate Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Ibandronate Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Ibandronate Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Ibandronate Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Ibandronate Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Ibandronate Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Ibandronate Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Ibandronate Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Ibandronate Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Ibandronate Revenue, (US$, Mn), 2023-2028
Table 30. Roche Corporate Summary
Table 31. Roche Ibandronate Product Offerings
Table 32. Roche Ibandronate Revenue (US$, Mn), (2017-2022)
Table 33. Apotex Corporate Summary
Table 34. Apotex Ibandronate Product Offerings
Table 35. Apotex Ibandronate Revenue (US$, Mn), (2017-2022)
Table 36. Mylan Corporate Summary
Table 37. Mylan Ibandronate Product Offerings
Table 38. Mylan Ibandronate Revenue (US$, Mn), (2017-2022)
Table 39. Sun Pharmaceutical Corporate Summary
Table 40. Sun Pharmaceutical Ibandronate Product Offerings
Table 41. Sun Pharmaceutical Ibandronate Revenue (US$, Mn), (2017-2022)
Table 42. Dr Reddy's Laboratories Corporate Summary
Table 43. Dr Reddy's Laboratories Ibandronate Product Offerings
Table 44. Dr Reddy's Laboratories Ibandronate Revenue (US$, Mn), (2017-2022)
Table 45. Aurobindo Pharma Corporate Summary
Table 46. Aurobindo Pharma Ibandronate Product Offerings
Table 47. Aurobindo Pharma Ibandronate Revenue (US$, Mn), (2017-2022)
Table 48. MACLEODS Corporate Summary
Table 49. MACLEODS Ibandronate Product Offerings
Table 50. MACLEODS Ibandronate Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Ibandronate Segment by Type in 2021
Figure 2. Ibandronate Segment by Application in 2021
Figure 3. Global Ibandronate Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Ibandronate Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Ibandronate Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Ibandronate Revenue in 2021
Figure 8. By Type - Global Ibandronate Revenue Market Share, 2017-2028
Figure 9. By Application - Global Ibandronate Revenue Market Share, 2017-2028
Figure 10. By Region - Global Ibandronate Revenue Market Share, 2017-2028
Figure 11. By Country - North America Ibandronate Revenue Market Share, 2017-2028
Figure 12. US Ibandronate Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Ibandronate Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Ibandronate Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Ibandronate Revenue Market Share, 2017-2028
Figure 16. Germany Ibandronate Revenue, (US$, Mn), 2017-2028
Figure 17. France Ibandronate Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Ibandronate Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Ibandronate Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Ibandronate Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Ibandronate Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Ibandronate Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Ibandronate Revenue Market Share, 2017-2028
Figure 24. China Ibandronate Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Ibandronate Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Ibandronate Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Ibandronate Revenue, (US$, Mn), 2017-2028
Figure 28. India Ibandronate Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Ibandronate Revenue Market Share, 2017-2028
Figure 30. Brazil Ibandronate Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Ibandronate Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Ibandronate Revenue Market Share, 2017-2028
Figure 33. Turkey Ibandronate Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Ibandronate Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Ibandronate Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Ibandronate Revenue, (US$, Mn), 2017-2028
Figure 37. Roche Ibandronate Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Apotex Ibandronate Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Mylan Ibandronate Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Sun Pharmaceutical Ibandronate Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Dr Reddy's Laboratories Ibandronate Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Aurobindo Pharma Ibandronate Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. MACLEODS Ibandronate Revenue Year Over Year Growth (US$, Mn) & (2017-2022)